AIDS Therapies

Africa's First Trial Of Generic AIDS Drugs Delayed Second Time

Published in AIDS Weekly, January 7th, 2002

A long-awaited program using cheap generic drugs to treat AIDS was delayed for the second time this fall, leaving millions of Nigerians wondering when they could begin treatment.

Only 10,000 adults and 5000 children out of the 3.5 million Nigerians said to have AIDS will be covered by the trial program, though the specific participants haven't yet been named. A Nigerian Ministry of Health official in the capital Abuja said shipments of antiretroviral medicines manufactured by Indian companies Cipla and Rambazy had arrived in Nigeria.

The official said, however, that unexpected "organizational delays" had slowed down the distribution of the medicines...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-01-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry